IL36G and asthma: Furthermore, IL-36γ can enhance the NF-kB expression in mouse lungs (111), and sustain the NF-kB activation in patients with severe uncontrolled asthma, promoting the production of inflammatory mediators during the pathogenic process of asthma (136).